VITROS Immunodiagnostic Products CEA Reagent Pack
System, Test, Carcinoembryonic Antigen. 510(k) K231517, from Ortho Clinical Diagnostics (Bridgend, GB). Product code DHX, class 2.
As of Nov 20, 2026, K231517 is an FDA 510(k) held by Ortho Clinical Diagnostics, substantially equivalent on Aug 23, 2023 after 90 days, with no recalls tied to it in FDA's recall database.
- Review time: 90 days
- Recalls: 0
For In Vitro Diagnostic Use Only For the quantitative measurement of carcinoembryonic antigen (CEA) concentration in human serum and plasma (EDTA or heparin) using the VITROS 5600 Integrated System, to aid in the prognosis and management of cancer patients in whom changing concentrations of CEA are observed.
- Vitros Immunodiagnostic Products Cea Reagent Pack/Calibrator/Range VerifiersK041322 · Ortho-Clinical Diagnostics, Inc. · Jun 17, 2004
- Access CEAK223921 · Beckman Coulter, Inc. · Sep 22, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 25, 2023
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files